Cooltube SRL
Cooltube reported total assets of 899,612 € at the end of the 2024 financial year (annual accounts filed with the NBB on 29 Sep 2025).
The score of Cooltube shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +84 % Total assets +42 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cooltube's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 141,551 € | ||||
| Equity | 726,555 € | ||||
| Cash | 108,094 € | ||||
| EBITDA | 203,858 € | ||||
| Total assets | 899,612 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 01 Oct 2024
- Year ended 31 Dec 2022filed on 04 Apr 2024
- Year ended 31 Dec 2021filed on 17 Aug 2022
- Year ended 31 Dec 2020filed on 25 Aug 2021
Cooltube's financial analysis
- Solvency80.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cooltube
Cooltube's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0478.884.545
- VAT number
- BE0478884545
- Peppol
- Registered · 0208:0478884545 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Nov 2002
- Registered office
- 2550 Kontich
- Latest accounts
- 2024 · filed on 29 Sep 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Cooltube (SRL) has been based in Kontich since 2002, active in: wholesale of pharmaceutical and medical goods. For 2024, it reports a net profit of 141,551 € and equity of 726,555 €; its revenue is not published. Its solvency stands at 80.8%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cooltube
Companies in the same business, of comparable size and area, outside its group.
- Roller Wholesale of pharmaceutical and medical goods Willebroek · balance sheet 167,766 €
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- F Care Systems Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €3.15m
- Project 12 Wholesale of pharmaceutical and medical goods Edegem · balance sheet 123,549 €
- Schwabe Pharma Belgium Wholesale of pharmaceutical and medical goods Kontich · balance sheet €3.13m
- Hospinova Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 509,654 €
- ALL Products Wholesale of pharmaceutical and medical goods Aalst · balance sheet 972,749 €
- Unit Communication - CBF Médical Wholesale of pharmaceutical and medical goods Gembloux · balance sheet 764,164 €
Frequently asked questions about Cooltube
What is the revenue of Cooltube?
Cooltube files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Cooltube?
In Belgium, the VAT number is the company number prefixed with BE: BE0478884545 for Cooltube, if the company is VAT-registered. Its company number (CBE) is 0478.884.545.
Where is the registered office of Cooltube?
According to the CBE register, the registered office of Cooltube is in 2550 Kontich.
What is the equity of Cooltube?
At the close of the 2024 financial year, the equity of Cooltube amounts to 726,555 €, a solvency of 80.8% of total assets.
Who manages Cooltube?
The register lists 1 active mandates at Cooltube. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cooltube
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →